| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 36 |
| 1 | FULVESTRANT | 33 |
| 2 | DENOSUMAB | 32 |
| 3 | ASPIRIN | 22 |
| 4 | ASPIRIN 325 MG | 22 |
| 5 | ASPIRIN 81 MG | 22 |
| 6 | LETROZOLE | 20 |
| 7 | RANITIDINE | 20 |
| 8 | ANASTROZOLE | 18 |
| 9 | PALBOCICLIB | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INAVOLISIB | 2 | 0.0030 |
| 1 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 2 | CABAZITAXEL | 5 | 0.0014 |
| 3 | TIVOZANIB | 2 | 0.0012 |
| 4 | FULVESTRANT | 33 | 0.0010 |
| 5 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 6 | CLEAR MINT, GEL TOOTHPASTE | 1 | 0.0009 |
| 7 | ADAGRASIB | 1 | 0.0009 |
| 8 | ADO-TRASTUZUMAB EMTANSINE | 7 | 0.0008 |
| 9 | ADEFOVIR DIPIVOXIL | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 1 | Kinase Inhibitor [EPC] | 37 |
| 2 | Corticosteroid [EPC] | 36 |
| 3 | Aromatase Inhibitor [EPC] | 35 |
| 4 | Estrogen Receptor Antagonist [EPC] | 33 |
| 5 | RANK Ligand Inhibitor [EPC] | 32 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 22 |
| 7 | Androgen Receptor Inhibitor [EPC] | 19 |
| 8 | Microtubule Inhibitor [EPC] | 18 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Endoglycosidase [EPC] | 3 | 0.0016 |
| 2 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 3 | Estrogen Receptor Antagonist [EPC] | 33 | 0.0008 |
| 4 | Autologous Cellular Immunotherapy [EPC] | 3 | 0.0005 |
| 5 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Benzothiazole [EPC] | 1 | 0.0004 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 9 | Calcitonin [EPC] | 1 | 0.0003 |